Fny Investment Advisers, LLC Atai Life Sciences N.V. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$3.03 - $5.32 $5,454 - $9,576	-1,800 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$4.66 - $7.66 $84,812 - $139,412	-18,200 Reduced 91.0%	1,800 $9,000
Q4 2021 Jan 10, 2022	BUY	$6.82 - $17.8 $136,400 - $356,000	20,000 New	20,000 $152,000
Q3 2021 Oct 13, 2021	SELL	$13.62 - $19.48 $681 - $974	-50 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$16.94 - $19.89 $847 - $994	50 New	50 $0

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $189M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.